Companies: 10,795·Total market cap: $144.5T
Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc.

XENENASDAQHealthcare● Active
$51.27
$-0.46(-0.89%)
Market Cap$4.0B
P/E Ratio—
52W High$63.95
52W Low$30
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Xenon Pharmaceuticals Inc. (XENE) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001582313 · XENE · NASDAQ · as of Jun 8, 2026

Filing snapshot

784
Total Filings
144
Latest Form
2026-06-05
Most Recent
2014
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001582313 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-26
Fiscal Year End
Feb 26, 2026
Accession No.
0001193125-26-076650
Primary Document
xene-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001582313 · Accession 0001193125-26-076650

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
8-K
2026-06-03Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
S-8 POSS-8 POS
S-8 POS
2026-06-03
View
S-8 POSS-8 POS
S-8 POS
2026-06-03
View
S-8 POSS-8 POS
S-8 POS
2026-06-03
View
S-8 POSS-8 POS
S-8 POS
2026-06-03
View
S-8 POSS-8 POS
S-8 POS
2026-06-03
View
S-8 POSS-8 POS
S-8 POS
2026-06-03
View
S-8 POSS-8 POS
S-8 POS
2026-06-03
View
S-8 POSS-8 POS
S-8 POS
2026-06-03
View
S-8 POSS-8 POS
S-8 POS
2026-06-03
View
S-8 POSS-8 POS
S-8 POS
2026-06-03
View
S-8Employee Stock Plan Registration
S-8
2026-06-03
View
8-KCurrent Report
8-K
2026-06-03
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
Showing 1–15 of 423 filingsForm 4 / 144 hidden· 784 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001582313  |  Exchange: NASDAQ · Healthcare

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) has submitted 784 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001582313, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Xenon Pharmaceuticals Inc.'s most comprehensive regulatory disclosure. The most recent Xenon Pharmaceuticals Inc. 10-K was filed on 2026-02-26 for fiscal year ending 2026. Historical XENE 10-K annual reports are available from 2013 through 2026.

Investors researching Xenon Pharmaceuticals Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
CNTA SEC Filings →LEGN SEC Filings →SRRK SEC Filings →APGE SEC Filings →CGON SEC Filings →CELC SEC Filings →TVTX SEC Filings →RARE SEC Filings →
→ XENE Financials→ XENE Earnings→ XENE Insider Trades

Frequently Asked Questions

XENE SEC Filings · 8 questions

Xenon Pharmaceuticals Inc. (XENE) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 784 filings and access original documents at no cost. Xenon Pharmaceuticals Inc.'s CIK is 0001582313.

XENE SEC filingsXenon Pharmaceuticals Inc. SEC documentsfind XENE 10-K